EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Variant ALK ‐fusion positive anaplastic large cell lymphoma ( ALCL ): A population‐based paediatric study of the NHL‐BFM study group

Jette Luedersen, Udo Zur Stadt, Julia Richter iD, Ilske Oschlies, Wolfram Klapper iD, Andreas Rosenwald, Marketa Kalinova, Ingrid Simonitsch-Klupp, Reiner Siebert, Martin Zimmermann, Minyue Qi, Jacqueline Nakel und 6 weitere

British Journal of Haematology · 2024-05 · 204 (5) · 1894-1898

DOI: 10.1111/bjh.19308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 26.01.2024. Verfasst von Jette Luedersen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Haematology and Oncology and NHL-BFM Study Centre, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Lymphoma, Large-Cell, Anaplastic, Anaplastic Lymphoma Kinase, Nucleophosmin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hamburger Stiftung zur Foerderung der Krebsbekaempfung, Juli Harnack scholarship of the Foerdergemeinschaft Kinderkrebszentrum Hamburg e.V., KinderkrebsInitiative Buchholz, Holm-Seppensen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Frequency, distribution and prognostic meaning of ALK ‐partner genes other than NPM1 in ALK‐positive anaplastic large‐cell lymphoma (ALCL) are unknown. Forty‐nine of 316 ALCL diagnosed in the NHL‐BFM study group showed no nuclear ALK expression suggestive of a variant ALK ‐partner; 41 were analysed by genomic capture high‐throughput sequencing or specific RT‐PCRs. NPM1::ALK was detected in 13 cases. Among the 28 patients with a non‐ NPM1::ALK ‐fusion partner, ATIC ( n = 8; 29%) and TPM3 ( n = 9; 32%) were the most common. Five of eight patients with ATIC::ALK ‐positive ALCL relapsed, none of nine with TPM3::ALK. Variant ALK‐partners are rare and potentially associated with different prognoses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large-Cell, AnaplasticAnaplastic Lymphoma KinaseNucleophosminHumansChildMaleFemaleAdolescentChild, PreschoolOncogene Proteins, FusionPrognosisNuclear ProteinsInfantTropomyosin

Stichwörter der Autor:innen

ALK positive ALCLnon‐Hodgkin's lymphomavariant ALK

Substanzen

Anaplastic Lymphoma KinaseNucleophosminALK protein, humanNPM1 protein, humanOncogene Proteins, FusionTPM3 protein, humanNuclear ProteinsTropomyosin

Autor:innen und Institutionen

  • Paediatric Haematology and Oncology and NHL-BFM Study Centre, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Paediatric Haematology and Oncology and CoALL Study Centre, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Pathology, Haematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Department of Pathology, University of Wuerzburg, Wuerzburg, Germany.
  • Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University Prague and University Hospital in Motol, Prague, Czech Republic.
  • Department of Pathology, 3rd Faculty of Medicine, Charles University Prague and University Hospital Kralovske Vinohrady, Prague, Czech Republic.

ORCID-Profile: Julia Richter, Wolfram Klapper, Andishe Attarbaschi, Wilhelm Woessmann, Christine Damm-Welk

Förderung

  • Hamburger Stiftung zur Foerderung der Krebsbekaempfung
  • Juli Harnack scholarship of the Foerdergemeinschaft Kinderkrebszentrum Hamburg e.V.
  • KinderkrebsInitiative Buchholz, Holm-Seppensen
  • Deutsche Kinderkrebsstiftung

Zitieren

APA

Luedersen, J., Stadt, U. Z., Richter, J., Oschlies, I., Klapper, W., Rosenwald, A., Kalinova, M., Simonitsch-Klupp, I., Siebert, R., Zimmermann, M., Qi, M., Nakel, J., Scheinemann, K., Knörr, F., Attarbaschi, A., Kabickova, E., Woessmann, W., & Damm-Welk, C. (2024). Variant ALK ‐fusion positive anaplastic large cell lymphoma ( ALCL ): A population‐based paediatric study of the NHL‐BFM study group. British Journal of Haematology, 204(5), 1894-1898. https://doi.org/10.1111/bjh.19308

Vancouver

Luedersen J, Stadt UZ, Richter J, Oschlies I, Klapper W, Rosenwald A, et al. Variant ALK ‐fusion positive anaplastic large cell lymphoma ( ALCL ): A population‐based paediatric study of the NHL‐BFM study group. British Journal of Haematology. 2024;204(5):1894-1898. doi:10.1111/bjh.19308

BibTeX
@article{Luedersen2024,
  author = {Luedersen, Jette and Stadt, Udo Zur and Richter, Julia and Oschlies, Ilske and Klapper, Wolfram and Rosenwald, Andreas and Kalinova, Marketa and Simonitsch-Klupp, Ingrid and Siebert, Reiner and Zimmermann, Martin and Qi, Minyue and Nakel, Jacqueline and Scheinemann, Katrin and Knörr, Fabian and Attarbaschi, Andishe and Kabickova, Edita and Woessmann, Wilhelm and Damm-Welk, Christine},
  title = {Variant ALK ‐fusion positive anaplastic large cell lymphoma ( ALCL ): A population‐based paediatric study of the NHL‐BFM study group},
  journal = {British Journal of Haematology},
  year = {2024},
  volume = {204},
  number = {5},
  pages = {1894--1898},
  doi = {10.1111/bjh.19308}
}
Kostenlos starten →